Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04981184
Other study ID # BE-2-67
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 22, 2019
Est. completion date September 30, 2024

Study information

Verified date October 2023
Source Lithuanian University of Health Sciences
Contact Ieva Žemaitiene, MCs
Phone +37064850985
Email ieva.zemaitiene@lsmu.lt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the biomedical research is to determine the informativeness and prognostic factors of surface electromyography by assessing the probability of recovery of balance and gait parameters in the second stage of rehabilitation of persons with cerebral infarction.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Cerebral infarction for the first time; - Age from 18 to 89 years old; - Muscle strength according to the Oxford scale is 3-5 points; - Able to walk without the help of others; - Is able to communicate and understand instructions properly; - Agrees to participate in the study (voluntary, explicit, informed written consent to participate). Exclusion Criteria: - Muscle strength according to the Oxford scale is 0-2 points; - Unable to walk without the help of others; - Sensorimotor aphasia or other perceptual disorders; - Do not sign the informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Gait and balance measurement
Virtual gait training procedures are included. Balance training procedures with Biodex Balance system are included too.

Locations

Country Name City State
Lithuania LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva Kaunas

Sponsors (1)

Lead Sponsor Collaborator
Lithuanian University of Health Sciences

Country where clinical trial is conducted

Lithuania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle strength by Oxford scale Testing key muscles from the lower extremities (muscle rectus femoris, muscle biceps femoris, muscle gastrocnemius, lateral head, muscle tibialis anterior) against the examiner's resistance and grading the patient's strength on a 0 (No contraction) to 5 (Movement against gravity with full resistance) scale. Baseline
Primary Gait analysis with surface electromyography: Load change (seconds) Time change heel to forefoot. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Maximum force (Newton) The average maximum force change reached in N/cm² for the three zones: toes, mid-foot and heel. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Maximum pressure (Newtons /square centimeter (N/cm²)) The average maximum pressure reached in N/cm² for the three zones: toes, mid-foot and heel (left and right legs separately). Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Time maximum force (percentage of stance time) The change of the average point in time within a gait cycle where the maximum values for the three zones: toes, mid-foot and heel were collected in Newton. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Contact time (percentage of stance time) The average contact time change of the three zone toes, mid-foot and heel as a percentage. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Length of the gait line (millimeters) The change from baseline of the progression of the center of pressure of all the steps recorded of one side of the body (left and right side of body separately). Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Anterior/Posterior Position (millimeters) The shift change forwards or backwards of the Center of pressure. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Lateral symmetry (millimeters) The change from baseline of the left /right shift of the center of pressure, taking all the steps into consideration. A negative value indicates a shift to the left, and a positive value, a shift to the right. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Step time (seconds) Time change during the phase within a gait cycle between the heel contact of one side of the body and the heel contact of the contralateral side. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Cadence (steps/minutes) Change from baseline of step frequency. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Velocity (kilometers/hour) Average gait speed change from baseline during the analyzed measuring interval (30 seconds). Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Stance phase (percentage) The phase of a gait cycle change in which the foot has contact with the ground. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Swing phase (percentage) Change from baseline of the phase of a gait cycle during which the foot has no contact with the ground. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Double stance phase (percentage) The phase change from baseline during a gait cycle that begins at contralateral initial contact (when the heel of the contralateral side touches the ground) and ends at toe off of the viewed side of the body. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Foot rotation (degree) The change from baseline of the angle between the longitudinal axis of the foot and the walking direction. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Step length (centimeters) Change of the distance between the heel contact of one side of the body and the heel contact of the contralateral side. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Stride length (centimeters) the distance change between two heel contacts on the same side of the body. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: Step width (centimeters) The distance change between the right and left foot. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Gait analysis with surface electromyography: surface electromyography signals (microvolts) Surface electromyography measurements of key muscles (muscle rectus femoris, muscle biceps femoris, muscle gastrocnemius, lateral head, muscle tibialis anterior) with a disposable dual surface electrode. Change of surface electromyography signals during walking on treadmill for 30 seconds. Baseline, approximately 2 days before the end of acute rehabilitation
Primary Stance analysis: Step width (centimeters) Change from baseline of the averaged load distribution of the left and right forefoot or heel, as well as the load distribution of the left and right contact surface in per cent. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): Postural Stability Test (Overall stability index) The BBS will be used to assess postural performance of participants. The movable platform of the BBS allows up to 20° of surface tilt in anterior-posterior and medial-lateral directions. The device is equipped with computer software (Biodex, version 3.1; Biodex Medical Systems). Platform Setting 8. Test Trial Time 20 secs. A high number is indicative of a lot of motion, which is indicative of the patient having trouble balancing. Change from baseline postural stability by overall stability index. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): Limits of Stability Test (seconds) During test, patients must shift their weight to move the cursor from the center target to a blinking target and back as quickly and with as little deviation as possible. Platform Setting STATIC. Direction control - OVERALL. Faster - better. Time change of limit of stability test. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): Limits of Stability Test (score) During test, patients must shift their weight to move the cursor from the center target to a blinking target and back as quickly and with as little deviation as possible. Platform Setting STATIC. Direction control - OVERALL. The goal - 65 scores and more. Score change of limit of stability test. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): A fall risk test (scores) Test results are compared to age dependent normative data. Scores higher than normative values suggest further assessment. Platform Setting 12-8. Test Trial Time 20 seconds. Direction control - OVERALL. Patient's aged 54-71 years' normative scores are 0.9-3.7 scores, 72-89 years' normative scores are 2-4 scores, 36-53 years' normative scores are 0.7-3.1 scores, 17-35 years' normative scores are 0.7-2.1 scores. Change from baseline a fall risk by scores. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): Clinical Test of Sensory Integration of Balance(CTSIB) (sway index) The test assesses how well a patient can integrate sensory information to maintain balance. Change from baseline the CTSIB test by the patient's sway index, which represents the mean absolute deviation of the patient's average position during a test. The higher the sway index, the more unsteady the person was during the test. Test Trial Time 30 seconds. The test performs with the patient standing on a firm and foam platform with the eyes open and closed. Measure Sway index of Composite Score. Baseline, approximately 2 days before the end of acute rehabilitation
Secondary Biodex Balance System (BBS): Balance Error Scoring System (sway index) A test consists of three positions (Double Leg Stance, Single Leg Stance and Tandem Leg Stance) on two types of platforms (firm and foam) for a total of six conditions. With the Balance System SD, time and error counting is replaced with a measure of sway. Change from baseline balancing errors by Sway index of Composite Score. The higher the sway index, the more unsteady the person was during the test. Test Trial Time 20 seconds Baseline, approximately 2 days before the end of acute rehabilitation
See also
  Status Clinical Trial Phase
Completed NCT05131295 - Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage. Phase 3
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Completed NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Recruiting NCT06076122 - Salicornia for Neurovascular Health Improve N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Recruiting NCT06270927 - A Feasibility Study for Randomization of Code Stroke Imaging Strategies
Completed NCT02912546 - Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study N/A
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT01673932 - Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke Phase 1
Recruiting NCT01556802 - Use of Minocicline in Patients With Stroke Phase 1
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Phase 3
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT04188132 - EEG Based BCI for Upper Limb Rehabilitation in Stroke N/A
Completed NCT01443962 - The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy N/A
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2